In particular, for [99mTc]Tc-DB4, these treatments were compared in mice bearing GRPR-positive human prostate adenocarcinoma PC-3 xenografts [30] and for [111In]In-SG4, in mice bearing a double A431-CCK2R((+/−)) tumor model [31]. The gene discussed is GRPR; the disease is neoplasm.